Association between Lipoprotein (a) level on admission and the incidence of subsequent cardiovascular events in patients with acute coronary syndrome

International Journal of Cardiology

Volumn 158, Issue 3, 2012, Pages 464-466

  Zhou, Jingmin ^a   Cui, Xiaotong ^a   Jin, Xuejuan ^a   Zhou, Jun ^a   Fu, Mingqiang ^a   Zhong, Chunlin ^a   Sun, Aijun ^a   Hu, Kai ^a   Fu, Michael ^b   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute coronary syndrome; Lipoprotein (a); Major adverse cardiovascular events; Risk factor

Indexed keywords

LIPOPROTEIN A;

ACUTE CORONARY SYNDROME; ADULT; AGED; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CORONARY ARTERY BYPASS SURGERY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

EID: 84863630363     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.05.013     Document Type: Article

References (23)

1. S. Yusuf, F. Zhao, and S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
2. A.R. Sharrett, C.M. Ballantyne, and S.A. Coady Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteinsA-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study Circulation 104 2001 1108 1113
3. A. von Eckardstein, H. Schulte, and P. Cullen Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk J Am Coll Cardiol 37 2001 434 439
4. G. Luc, J.M. Bard, and D. Arveiler Lipoprotein (a) as a predictor of coronary heart disease: the PRIME study Atherosclerosis 163 2002 377 384
5. A.A. Ariyo, C. Thach, and R. Tracy Lp(a) lipoprotein, vascular disease, and mortality in the elderly N Engl J Med 349 2003 2108 2115
6. N. Rifai, J. Ma, and F.M. Sacks Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: the physicians' health study Clin Chem 50 2004 1364 1371
7. A. Gaw, H.M. Murray, and E.A. Brown Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Atherosclerosis 180 2005 381 388
8. J.S. Danik, N. Rifai, and J.E. Buring Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women JAMA 296 2006 1363 1370
9. P.R. Kamstrup, M. Benn, and A. Tybjærg-Hansen Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study Circulation 117 2008 176 184
10. W.Y. Craig, L.M. Neveux, and G.E. Palomaki Lipoprotein(a) as a risk factor for ischemic heart disease: meta-analysis of prospective studies Clin Chem 44 1998 2301 2306
11. S.S. Virani, A. Brautbar, and B.C. Davis Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: The Atherosclerosis Risk in Communities (ARIC) Study Circulation 125 2 2012 241 249
12. S. Erqou, S. Kaptoge, and P.L. Perry Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 2009 412 423
13. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2
14. J.S. Danik, N. Rifai, and J.E. Buring Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events J Am Coll Cardiol 52 2008 124 131
15. G.M. Kostner, P. Avogaro, and G. Cazzolato Lipoprotein (a) and the risk for myocardial infarction Atherosclerosis 38 1981 51 61
16. M. Sandkamp, H. Funke, and H. Schulte Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age Clin Chem 38 1990 20 25
17. T. Murase, M. Okubo, and M. Amemiya-Kudoa Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus Metabolism 57 2008 791 795
18. P.S. Low, C.K. Heng, and N. Saha Racial variation of cord plasma lipoprotein(a) levels in relation to coronary risk level: a study in three ethnic groups in Singapore Pediatr Res 40 1996 718 722
19. J.Y. Cho, M.H. Jeong, and Y. Ahn High Lipoprotein(a) levels are associated with long-term adverse outcomes in acute myocardial infarction patients in high Killip classes Korean Circ J 40 2010 491 498
20. S. Sunayama, H. Daida, and H. Mokuno Lack of increased coronary atherosclerotic risk due to elevated lipoprotein(a) in women > or = 55 years of age Circulation 94 1996 1263 1268
21. L.A. Simons, Y. Friedlander, and J. McCallum Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo study Atherosclerosis 99 1993 87 95
22. V. Solfrizzi, F. Panza, and A.M. Colacicco Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > 65 years of age (The Italian Longitudinal Study on Aging) Am J Cardiol 89 2002 825 829
23. S.M. Grundy National Cholesterol Education Program: second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II) Circulation 89 1994 1329 1445